Skip to main content
OpenTrials
Completed

NCT Number: NCT02032615

Let's be Well Red: Efficacy of Gudness Bars in Improving the Hemoglobin and Hematocrit Levels of Anemic Subjects

To test the efficacy of Gudness Bars in improving the hemoglobin and hematocrit levels of anemic subjects longitudinally.

To quantify the demographics of subjects attending anemia testing camps through LBWR and to explore correlations with the demographics data.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Lets Be Well Red

Mumbai, Maharashtra, 400092, India

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Ages 18-35 years age

Exclusion criteria

  • Known allergy towards nuts.

Treatment and study plan

Education plus Gudness Nutritional Bar

Dietary Supplement

Education

Other

Other names: Education about Anemia

Primary outcomes

  1. Hemoglobin level

    Time frame: 3 months

    Measure hemoglobin levels before and after administration of Gudness nutrition bar.

  2. Hematocrit level

    Time frame: 3 months

    Measure Hematocrit levels before and after administration of Gudness nutrition bar.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Registry information

Official study title

Let's Be Well Red (LBWR)

Acronym: LBWR

Important dates

Study start
2014
Primary completion
2014
Study completion
2015
First posted
Jan 10, 2014
Registry last updated
Nov 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.